Staar Surgical Co (STAA)
As of Sep 20, 2026, Staar Surgical Co (STAA) scores 3.7/10 on AlphaStocks' five-model composite, #146 of 168 Health Care stocks. At $21, STAA trades 78% above its model fair value of $12.
Health Care / Health Care Equipment
S&P SmallCap 600$20.82
Scores poorly across most models. Proceed with caution.
Weak
Score based on 3 of 5 models — moderate confidence
Data as of Sep 20, 2026
Is STAAR SURGICAL CO a Good Investment in 2026?
STAAR SURGICAL CO (STAA) scores 3.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating STAAR SURGICAL CO as Caution. However, the Graham model rates it Caution. STAAR SURGICAL CO currently trades 78% above its estimated fair value of $12. STAAR SURGICAL CO ranks #146 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value — the market may be pricing in future growth.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Caution
1/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is STAAR SURGICAL CO (STAA) a good investment?
What is STAAR SURGICAL CO's Piotroski F-Score?
Is STAA overvalued or undervalued?
How does STAA compare to other Health Care stocks?
What do investment models say about STAA?
Similar Stocks
Compare STAA with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer